• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Owens & Minor Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

    5/10/24 8:30:20 AM ET
    $OMI
    Medical Specialities
    Health Care
    Get the next $OMI alert in real time by email
    0000075252false00000752522024-05-092024-05-09

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 9, 2024

    Owens & Minor, Inc.

    (Exact name of registrant as specified in its charter)

    ​

    ​

    ​

    ​

    ​

    Virginia

    001-09810

    ​

    54-1701843

    (State or other jurisdiction of

    (Commission

    ​

    (I.R.S. Employer

    incorporation or organization)

    File Number)

    ​

    Identification No.)

    ​

    ​

    ​

    ​

    9120 Lockwood Boulevard,

    Mechanicsville, Virginia

    ​

    ​

    23116

    (Address of principal executive

    ​

    ​

    ​

    offices)

    ​

    ​

    (Zip Code)

    ​

    ​

    ​

    ​

    Post Office Box 27626,

    ​

    ​

    ​

    Richmond, Virginia

    ​

    ​

    23261-7626

    (Mailing address of principal

    ​

    ​

    ​

    executive offices)

    ​

    ​

    (Zip Code)

    ​

    Registrant’s telephone number, including area code (804) 723-7000

    Securities registered pursuant to Section 12(b) of the Act:

    ​

    ​

    ​

    ​

    ​

    ​

    Title of each class

        

    Trading Symbol(s)

        

    Name of each exchange on which registered

    Common Stock, $2 par value per share

    ​

    OMI

    ​

    New York Stock Exchange

    ​

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

    ​

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ​

    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ​

    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ​

    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    ​

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company         ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.          ◻

    ​

    ​

    ​

    Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On May 9, 2024 at the 2024 Annual Meeting of Shareholders (the “Annual Meeting”) of Owens & Minor, Inc. (the “Company”), the shareholders approved Amendment No. 1 (the “Amendment”) to the Owens & Minor, Inc. 2023 Omnibus Incentive Plan (the “2023 Plan”). The description of the Amendment included in the Company's proxy statement filed with the Securities and Exchange Commission on March 27, 2024 is incorporated herein by reference.

    ​

    Under the terms of the 2023 Plan, as amended by the Amendment, the Board of Directors (the “Board”) has authorized the Our People & Culture Committee of the Board to grant equity and other incentive awards to employees, non-employee directors and consultants. Each equity grant made pursuant thereto will be evidenced by an agreement between the Company and the person named therein.

    ​

    Item 5.07Submission of Matters to a Vote of Security Holders.

    At the Company’s Annual Meeting on May 9, 2024, the matters described below were voted upon and approved as indicated. There were 76,598,351 shares of common stock entitled to vote at the meeting and 70,719,273 shares were voted in person or by proxy (approximately 92.32% of shares entitled to vote).

    ​

    (1)Election of nine directors, each for a one-year term, as follows:

    ​

    Director

    Votes For

    Votes Against

    Abstentions

    Broker

    Non-Votes

    Mark A. Beck

    66,891,207

    684,202

    30,087

    3,113,777

    Gwendolyn M. Bingham

    66,827,630

    753,451

    24,415

    3,113,777

    Kenneth Gardner-Smith

    67,076,877

    496,810

    31,809

    3,113,777

    Robert J. Henkel

    67,012,152

    560,864

    32,480

    3,113,777

    Rita F. Johnson-Mills

    66,918,229

    661,973

    25,294

    3,113,777

    Stephen W. Klemash

    67,347,354

    208,945

    49,197

    3,113,777

    Teresa L. Kline

    67,234,485

    345,544

    25,467

    3,113,777

    Edward A. Pesicka

    67,351,295

    220,911

    33,290

    3,113,777

    Carissa L. Rollins

    67,234,922

    345,316

    25,258

    3,113,777

    ​

    (2)Ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 as follows:

    ​

    Votes

    ​

    Votes For

    Votes Against

    Abstentions

    Broker

    Non-Votes

    69,207,654

    1,471,594

    40,025

    -

    ​

    ​

    (3)Approval of Amendment No. 1 to the Owens & Minor, Inc. 2023 Omnibus Incentive Plan, as follows:

    ​

    Votes

    ​

    Votes For

    Votes Against

    Abstentions

    Broker

    Non-Votes

    64,181,423

    3,371,256

    52,817

    3,113,777

    ​

    (4)Advisory vote to approve the compensation of our named executive officers as follows:

    ​

    Votes

    ​

    Votes For

    Votes Against

    Abstentions

    Broker

    Non-Votes

    66,163,767

    1,381,531

    60,198

    3,113,777

    ​

    ​

    ​

    ​

    ​

    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    OWENS & MINOR, INC.

    ​

    ​

    Date: May 10, 2024

    By:

    /s/ Heath H. Galloway

    ​

    Name:

     ​

    Heath H. Galloway

    ​

    Title:

    ​

    Executive Vice President, General Counsel and Corporate Secretary

    ​

    ​

    ​

    ​

    Get the next $OMI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OMI

    DatePrice TargetRatingAnalyst
    11/3/2025$4.00Buy → Neutral
    UBS
    7/19/2024$24.00 → $19.00Neutral → Buy
    Citigroup
    2/26/2024$24.00Market Perform
    Leerink Partners
    1/3/2024$21.00Equal Weight
    Barclays
    10/13/2022$52.00 → $18.00Buy → Neutral
    Citigroup
    10/12/2022$43.00 → $17.00Buy → Underperform
    BofA Securities
    10/12/2022$62.00 → $22.00Outperform → Neutral
    Robert W. Baird
    4/26/2022$55.00Buy
    Citigroup
    More analyst ratings

    $OMI
    SEC Filings

    View All

    Amendment: Owens & Minor Inc. filed SEC Form 8-K: Financial Statements and Exhibits

    8-K/A - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)

    1/5/26 4:05:19 PM ET
    $OMI
    Medical Specialities
    Health Care

    Owens & Minor Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure

    8-K - OWENS & MINOR INC/VA/ (0000075252) (Filer)

    12/31/25 4:15:43 PM ET
    $OMI
    Medical Specialities
    Health Care

    Owens & Minor Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

    8-K - OWENS & MINOR INC/VA/ (0000075252) (Filer)

    12/18/25 4:18:47 PM ET
    $OMI
    Medical Specialities
    Health Care

    $OMI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity

    The Transaction Includes the Owens & Minor Brand, and the Remaining Company Will Become Accendra Health Completes the Company's Transformation into a Pure Play Leader in the Home-Based Care Market Owens & Minor, Inc. (NYSE:OMI) (the "Company") announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc. "Today's announcement marks an inflection point in the strategic transformation of Owens & Minor into Accendra Health, a leading nationwide pure play home based care platform. The completion of the sale of the P&HS segment enables the Comp

    12/31/25 4:05:00 PM ET
    $OMI
    Medical Specialities
    Health Care

    Owens & Minor Announces Corporate Name Change to Accendra Health, Inc.

    Accendra Health To Trade Under the "ACH" Symbol on the New York Stock Exchange Owens & Minor, Inc. (NYSE:OMI) ("the Company") today announced that it will change its name to Accendra Health, Inc. with an anticipated effective date of December 31, 2025. The name change affects only the name of the parent corporation and is intended to better reflect the Company's strategic direction and future organizational focus as a leader in the home-based care market. The Company will continue to use and operate under the Apria and Byram Healthcare brands. "The renaming of our organization is another milestone in the strategic transformation of our company as a leading, pure play home-based care busin

    12/18/25 4:05:00 PM ET
    $OMI
    Medical Specialities
    Health Care

    Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025

    Owens & Minor, Inc. (NYSE:OMI) announced today that members of its management team are scheduled to participate in two upcoming investor conferences. Citi 2025 Global Healthcare Conference On Tuesday, December 2, 2025, Ed Pesicka, the Company's President and Chief Executive Officer, and Will Parrish, the Company's Vice President of Strategy, Corporate Development, & Investor Relations, are scheduled to participate in a fireside chat at 2:30 P.M. ET and host one-on-one investor meetings at the conference in Miami, Florida. Please visit the "Events & Presentations" section of the "Investor Relations" page on the Owens & Minor website available at https://investors.owens-minor.com at least

    12/2/25 7:00:00 AM ET
    $OMI
    Medical Specialities
    Health Care

    $OMI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Coliseum Capital Management, Llc bought $8,099,544 worth of shares (1,537,852 units at $5.27) (SEC Form 4)

    4 - OWENS & MINOR INC/VA/ (0000075252) (Issuer)

    8/14/25 8:23:48 PM ET
    $OMI
    Medical Specialities
    Health Care

    Large owner Coliseum Capital Management, Llc bought $3,073,750 worth of shares (410,000 units at $7.50) (SEC Form 4)

    4 - OWENS & MINOR INC/VA/ (0000075252) (Issuer)

    4/10/25 9:43:55 PM ET
    $OMI
    Medical Specialities
    Health Care

    Large owner Coliseum Capital Management, Llc bought $4,291,218 worth of shares (528,356 units at $8.12) (SEC Form 4)

    4 - OWENS & MINOR INC/VA/ (0000075252) (Issuer)

    4/7/25 8:21:15 PM ET
    $OMI
    Medical Specialities
    Health Care

    $OMI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Owens & Minor downgraded by UBS with a new price target

    UBS downgraded Owens & Minor from Buy to Neutral and set a new price target of $4.00

    11/3/25 9:08:29 AM ET
    $OMI
    Medical Specialities
    Health Care

    Owens & Minor upgraded by Citigroup with a new price target

    Citigroup upgraded Owens & Minor from Neutral to Buy and set a new price target of $19.00 from $24.00 previously

    7/19/24 7:41:01 AM ET
    $OMI
    Medical Specialities
    Health Care

    Leerink Partners initiated coverage on Owens & Minor with a new price target

    Leerink Partners initiated coverage of Owens & Minor with a rating of Market Perform and set a new price target of $24.00

    2/26/24 8:10:20 AM ET
    $OMI
    Medical Specialities
    Health Care

    $OMI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CEO P&HS Long Andrew G gifted 47,908 shares, decreasing direct ownership by 18% to 214,064 units (SEC Form 4)

    4 - OWENS & MINOR INC/VA/ (0000075252) (Issuer)

    11/20/25 4:11:13 PM ET
    $OMI
    Medical Specialities
    Health Care

    EVP & CFO Leon Jonathan A covered exercise/tax liability with 4,265 shares, decreasing direct ownership by 2% to 218,522 units (SEC Form 4)

    4 - OWENS & MINOR INC/VA/ (0000075252) (Issuer)

    9/24/25 4:07:31 PM ET
    $OMI
    Medical Specialities
    Health Care

    Large owner Coliseum Capital Management, Llc bought $8,099,544 worth of shares (1,537,852 units at $5.27) (SEC Form 4)

    4 - OWENS & MINOR INC/VA/ (0000075252) (Issuer)

    8/14/25 8:23:48 PM ET
    $OMI
    Medical Specialities
    Health Care

    $OMI
    Leadership Updates

    Live Leadership Updates

    View All

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H

    9/5/25 6:34:00 PM ET
    $ACHC
    $APP
    $BGS
    Medical Specialities
    Health Care
    Computer Software: Programming Data Processing
    Technology

    Owens & Minor Names Tammy Gomez EVP and Chief Human Resources Officer

    Gomez assumes leadership of Owens & Minor's people strategy with a focus on cultivating talent that supports company performance Owens & Minor, Inc. (NYSE:OMI), a leading global healthcare solutions company, today announced the appointment of Tammy Gomez as Executive Vice President & Chief Human Resources Officer, effective July 11, 2022. Gomez will report to Owens & Minor's President and Chief Executive Officer, Edward A. Pesicka, and be a member of the company's executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220622005306/en/Owens & Minor names Tammy Gomez EVP and Chief Human Resources Officer, effect

    6/22/22 6:50:00 AM ET
    $OMI
    Medical Specialities
    Health Care

    $OMI
    Financials

    Live finance-specific insights

    View All

    Owens & Minor Reports Third Quarter 2025 Financial Results

    Signed Definitive Agreement for the Sale of Products & Healthcare Services Segment Transaction Positions the Company as a Pure-Play Home-Based Care Business Owens & Minor, Inc. (NYSE:OMI) today reported financial results for the third quarter ended September 30, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. "Our recent announcement on the sale of our Products & Healthcare Services segment is another meaningful step in our strategy to pivot our focus to the more attractive home-based care space. We are keenly focused on reshaping ou

    10/30/25 4:05:00 PM ET
    $OMI
    Medical Specialities
    Health Care

    Owens & Minor Announces Date and Time Change of Third Quarter 2025 Financial Results and Conference Call

    Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the third quarter of 2025 on Thursday, October 30, 2025, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast c

    10/16/25 6:30:00 AM ET
    $OMI
    Medical Specialities
    Health Care

    Owens & Minor Announces Definitive Agreement to Divest Products & Healthcare Services Segment to Platinum Equity for $375mm in Cash and a Retained Equity Stake

    Transforms Owens & Minor into a Pure Play Market Leader in the Home-Based Care Market 5% Retained Equity Stake Provides Ability to Realize Future Value Creation Under Platinum Equity Preserves Tax Attributes in Excess of $150 Million Owens & Minor, Inc. (NYSE:OMI) today announced that it has entered into a definitive agreement for the sale of the Company's Products & Healthcare Services (P&HS) segment to Platinum Equity. Over the last several years, Owens & Minor has been strategically moving towards expanding its leadership position in the very attractive home-based care space. This transaction will allow the Company to focus on a simpler business model and allow for a more appropria

    10/7/25 4:15:00 PM ET
    $OMI
    Medical Specialities
    Health Care

    $OMI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Owens & Minor Inc.

    SC 13G/A - OWENS & MINOR INC/VA/ (0000075252) (Subject)

    11/12/24 10:32:12 AM ET
    $OMI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Owens & Minor Inc. (Amendment)

    SC 13G/A - OWENS & MINOR INC/VA/ (0000075252) (Subject)

    2/13/24 5:12:07 PM ET
    $OMI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Owens & Minor Inc. (Amendment)

    SC 13G/A - OWENS & MINOR INC/VA/ (0000075252) (Subject)

    2/12/24 5:29:41 PM ET
    $OMI
    Medical Specialities
    Health Care